Yuan, Tanwei
Tagscherer, Katrin E.
Roth, Wilfried
Bewerunge-Hudler, Melanie
Brobeil, Alexander
Kloor, Matthias
Bläker, Hendrik
Brenner, Hermann
Hoffmeister, Michael
Funding for this research was provided by:
the German Research Council (BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, CH 117/1-1, HO 5117/2-1, HO 5117/2-2, HE 5998/2-1, HE 5998/2-2, KL 2354/3-1, KL 2354 3-2, RO 2270/8-1, RO 2270/8-2, BR 1704/17-1, BR 1704/17-2)
the Interdisciplinary Research Program of the National Center for Tumor Diseases (NCT), Germany
the German Federal Ministry of Education and Research (01KH0404, 01ER0814, 01ER0815, 01ER1505A, 01ER1505B, 01KD2104A)
Deutsches Krebsforschungszentrum (DKFZ)
Article History
Received: 3 December 2024
Accepted: 7 June 2025
First Online: 3 July 2025
Declarations
:
: The DACHS study was approved by the ethics committees of the Medical Faculty of Heidelberg University and the state medical boards of Baden-Wuerttemberg and Rhineland-Palatinate (Approval number: 310/2001). All participants provided informed consent to participate this study.
: Not applicable.
: The authors declare no competing interests.